Yarrow Bioscience (YARW) Profit After Tax (2016 - 2026)

Yarrow Bioscience (YARW) has 11 years of Profit After Tax data on file, last reported at -$3.6 million in Q1 2026.

• Quarterly Profit After Tax rose 58.46% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.0 million (up 28.78% YoY) and the FY2025 annual result came in at -$26.5 million, up 33.53% from the prior year.
• Profit After Tax climbed to -$3.6 million in Q1 2026, from -$5.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $4.7 million in Q1 2022 to a low of -$12.1 million in Q3 2024.
• A 5-year average of -$7.1 million and a median of -$7.8 million in 2022 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax jumped 142.94% — and 2023, when it sank 220.17%.
• Tracing YARW's Profit After Tax over 5 years: stood at -$7.8 million in 2022, then rose by 20.6% to -$6.2 million in 2023, then sank by 95.5% to -$12.0 million in 2024, then jumped by 52.23% to -$5.8 million in 2025, then soared by 37.71% to -$3.6 million in 2026.
• The last three Profit After Tax figures came in at -$3.6 million (Q1 2026), -$5.8 million (Q2 2025), and -$8.6 million (Q1 2025), per Business Quant data.